301301SZSE

Yili Chuan Neng Biotechnology Co., Ltd. Independent Director 2025 Performance Report - Duan Hong

Yili Chuannig Biotechnology Co., Ltd.··6 pages

✨ AI Summary

This report details the independent director's performance in 2025, focusing on attendance, communication with stakeholders, and oversight of company operations and governance. The director actively participated in meetings, reviewed financial reports, and engaged with internal and external auditors to ensure compliance and protect shareholder interests. No independence-impacting issues were identified.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Ilyili Chuan Neng Biotechnology Co., Ltd. Independent Director 2025 Performance Report

As an independent director of Yili Chuan Neng Biotechnology Co., Ltd. (hereinafter referred to as the "Company"), I, Duan Hong, have strictly performed my duties in accordance with the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Company Articles of Association," and the "Administrative Measures for Independent Directors of Listed Companies" in 2025. With a diligent and responsible work attitude, I actively attended relevant meetings, voted in accordance with the law, effectively promoted the standardized operation of the Company, and fully played the role of an independent director. The 2025 performance report is as follows:

I. Statement on Personal Independence

(I) Personal Background

Born in 1964, Chinese national, with no permanent overseas residency, a member of the Communist Party of China, holding a doctoral degree, and possessing qualifications as a Senior Accountant, Certified Public Accountant, and Certified Tax Agent. I previously served as an independent director for Tianxiang Environment Co., Ltd. and Haitai Water Group Co., Ltd., and as an associate professor at Southwest Jiaotong University's School of Economics and Management. I am currently an independent director for the Company and Chengdu Olin Biotechnology Co., Ltd. I have obtained the Independent Director Qualification Certificate issued by the Shenzhen Stock Exchange.

(II) Statement on Circumstances Affecting Independence

  1. Neither I nor my lineal relatives or main social relations are employed by the Company or its affiliated enterprises, nor do we directly or indirectly hold more than 1% of the Company's issued shares. We are not among the top ten shareholders, nor are we employed by any shareholder unit that directly or indirectly holds more than 5% of the Company's issued shares or by any of the top five shareholder units. We are not employed by the Company's actual controller or its affiliated enterprises.
  2. I have not provided financial, legal, consulting, or other services to the Company or its controlling shareholders or their respective affiliated enterprises. I have not received any additional, undisclosed benefits from the Company, its major shareholders, or related parties.
  3. I do not hold any positions in the Company other than that of an independent director, nor do I hold any positions in the Company's major shareholders. There are no other significant relationships between myself, the Company, the Company's management, and any parties that could influence my independent and objective judgment. Therefore, there are no circumstances affecting the Company's independence.

II. 2025 Performance

(I) Attendance

  1. In 2025, my attendance record is as follows:
Meeting CategoryNumber of Meetings AttendedNumber of Meetings Personally AttendedNumber of Meetings Attended by ProxyNumber of AbsencesWhether Personally Attended Two Consecutive MeetingsRemarks
Board of Directors5500NoReviewed all proposals independently and prudently, voting in favor. No objections, negative votes, or abstentions were recorded.
Shareholders' Meeting3300NoReviewed all proposals independently and prudently, voting in favor. No objections, negative votes, or abstentions were recorded.
Audit Committee6600NoReviewed all proposals independently and prudently, voting in favor. No objections, negative votes, or abstentions were recorded.
Remuneration and Assessment Committee1100NoReviewed all proposals independently and prudently, voting in favor. No objections, negative votes, or abstentions were recorded.
Strategy and ESG Committee1100NoReviewed all proposals independently and prudently, voting in favor. No objections, negative votes, or abstentions were recorded.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.